CURRICULUM VITAE
Michael Putman MD
Michael Putman MD
Assistant Professor
Department of Medicine
Division of Rheumatology
Department of Medicine
Division of Rheumatology
OFFICE ADDRESS: |
Froedtert and Medical College Pavilion |
9200 W Wisconsin Ave |
Milwaukee, WI 53226 |
EDUCATION: |
07/2005 - 06/2009 Bachelor of Arts. Vanderbilt University College of Arts and Science, Nashville, TN |
07/2009 - 06/2013 Medical Doctor. University of Chicago Pritzker School of Medicine, Chicago, IL |
07/2014 - 06/2016 MERITS Medical Education Fellowship. University of Chicago, Chicago, IL |
07/2018 - 06/2020 Master of Science in Clinical Investigation. Northwestern Graduate School, Chicago, IL |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
07/2013 - 06/2016 Medical Resident, Internal Medicine Resident. Department of Medicine, University of Chicago, Chicago, IL |
07/2016 - 06/2017 Chief Resident. Mercy Hospital and Medical Center, Chicago, IL |
07/2017 - 06/2019 Rheumatology Fellowship, Rheumatology Fellow. Department of Rheumatology, Northwestern Medicine, Chicago, IL |
FACULTY APPOINTMENTS: |
07/2019 - 06/2020 Clinical Instructor of Rheumatology. Northwestern Medicine, Chicago, IL |
08/2020 - Present Assistant Professor of Medicine, Medical College of Wisconsin, Milwaukee, WI |
EDUCATIONAL ADMINISTRATIVE APPOINTMENTS: |
09/15/2020 - 07/01/2024 Associate Program Director - Rheumatology Fellowship, Medicine, Rheumatology, Medical College of Wisconsin |
03/22/2022 - 03/22/2023 Block Director, Hematology & Immunology, Medical College of Wisconsin |
06/01/2022 - 06/01/2023 Critical Thinking Thread Developer, Medical College of Wisconsin |
08/01/2022 - Present Associate Program Director, Internal Medicine Residency, Medicine, Medical College of Wisconsin |
07/01/2024 - Present Fellowship Program Director - Rheumatology, Medicine, Rheumatology, Medical College of Wisconsin |
HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS: |
09/01/2020 - Present Medical Director, Vasculitis Program, Medicine, Rheumatology, Medical College of Wisconsin |
HOSPITAL STAFF PRIVILEGES: |
08/2020 - Present Rheumatologist, Zablocki VA Medical Center, 5000 W. National Avenue, Milwaukee, WI 53214 |
08/2020 - Present Rheumatologist, Froedtert Hospital, 9200 W. Wisconsin Ave., Milwaukee, WI 53226 |
SPECIALTY BOARDS AND CERTIFICATION: |
Licensure | Number | Issue Date | Expiration |
Wisconsin License | 72734 | 10/31/2025 | |
AWARDS AND HONORS: |
2009 Summa Cum Laude Latin Honors |
2014 MERITS Medical Education Fellow |
2015 Johns Hopkins GIM Jeremy Sugarman House-staff Research Award |
2016 Arnold P. Gold Foundation Humanism and Excellence in Teaching Award |
2018 Feinberg Outstanding Teacher Award for the Medical Decision-Making Course |
2018 Northwestern University Department of Medicine Excellence in Teaching Award |
2018 - 2020 National Institutes of Health T-32 Ruth L. Kirschstein National Research Service Award |
2019 Northwestern University Department of Medicine Excellence in Teaching Award |
2020 - 2022 Rheumatology Research Foundation Scientist Development Grant |
2022 - 2023 Outstanding Medical Student Teacher, Medical College of Wisconsin |
2023 Best Academic Half Day or Ambulatory Lecturer, Medical College of Wisconsin Internal Medicine Residency |
2024 Susan and James Cerletty Mentorship Award, Department of Medicine |
2024 Best Academic Half Day or Ambulatory Lecturer, Medical College of Wisconsin Internal Medicine Residency |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
01/01/2015 - Present American College of Rheumatology (Member) |
EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS: |
Editorship |
11/09/2020 - Present Associate Editor, "Rheumatology" |
Ad-Hoc Reviewer |
01/01/2018 - Present Arthritis Research and Therapy |
01/01/2019 - Present Journal of Rheumatology |
01/01/2019 - Present Rheumatology |
01/01/2019 - Present Seminars in Arthritis and Rheumatism |
01/01/2020 - Present ACR Open |
06/14/2021 - Present Lancet Rheumatology |
LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
10/01/2024 - Present Secretary, Wisconsin Rheumatism Association |
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
01/01/2018 - 01/01/2021 Member, Fellows In-Training Committee, American College of Rheumatology |
10/01/2020 - 11/14/2022 ACR Ambassador, Annual Meeting, American College of Rheumatology |
05/01/2022 - 07/01/2022 Member, Abstract Selection Committee, American College of Rheumatology |
05/01/2023 - 07/01/2023 Member, Abstract Selection Commmittee, American College of Rheumatology |
05/01/2023 - Present Co-Director, Conference Leadership Group, Advances in Rheumatology and Technology Symposium |
06/01/2023 - 11/10/2025 Leadership Team, Knowledge Bowl, American College of Rheumatology |
06/01/2023 - Present Committee Member, Annual Meeting Planning Committee, American College of Rheumatology |
05/01/2024 - 07/01/2024 Abstract Selection Committee, American College of Rheumatology |
INTERNATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
05/01/2021 - Present Member, Clinical and Scientific Committee, Global Rheumatology Alliance |
04/03/2022 - 04/06/2022 Faculty, 20th International Vasculitis and ANCA Workshop |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
International |
"Conducting Research Using Online Tools", SGPGI SoMe Clinical Course, Sanjay Gandhi Postgraduate Institute of Medical Sciences, 01/23/2020 |
"Rheumatology Epistemology", Rheumatology Grand Rounds, Manchester, UK, 06/11/2020 |
“Publishing in the digital age", ACR / EULAR International Exchange Program - Focus Facilitator, Virtual Program, 12/11/2020 |
"The Changing Face of Autoimmune Education", Royal Society of Medicine - Nephrology UKIVAS, London, England, 11/17/2021 |
"Social Media and Digital Sources in Rheumatology", EULAR 2022 Congress, Copenhagen, Denmark, 01/06/2022 |
"Misconceptions & Opportunities Evidence-based Medicine in Rheumatology", Irish Society of Rheumatology, Dublin, Ireland, 05/04/2023 |
"Putting Evidence to Practice: Practical Recs for Rheums", NHS Foundation Trust Rheumatology Training Day, Bath, United Kingdom, 06/21/2023 |
"ANCA Vasculitis & Evidence Based Medicine: Critical Appraisal of Recent Trials", Bristol Regional CTD and Vasculitis Conference, Bristol, England, 09/21/2023 |
"The New Paradigm of PMR Treatment", PMR Webinar, Dublin, Ireland, 05/30/2024 |
"Careers in Research: Finding Mentorship", EMEUNET International Exchange, EULAR, 12/05/2024 |
National |
"Evidence Based Medicine: 10 Tips to Improve your Practice", ACR Annual Meeting, Atlanta, GA, 11/04/2019 |
"Keeping Up with the Literature", ACR Convergence, Virtual Annual Meeting, 11/09/2020 |
"2021 Vasculitis Guidelines", Collaboration with the Vasculitis Foundation, 03/01/2021 - 09/01/2021 |
"Keeping Up with the Medical Literature", ACR Convergence, ACR Annual Meeting, 11/08/2021 |
"Difficult and Challenging Cases in Vasculitis: Vasculitis Community Hub", ACR Convergence, ACR Annual Meeting, 11/09/2021 |
"Closing Session: A Look Beyond: Open Reflection & Future Innovation", American College of Rheumatology Annual Meeting, San Francisco, 11/09/2021 |
“Keeping Current for Peds Rheum”, Montefiore Grand Rounds, New York, New York, 01/24/2022 |
"Evidence Based Medicine and Rheumatology", Beth Israel Deaconess Medical Center - Grand Rounds, Boston, MA, 01/27/2022 |
"Parsing the Primary Literature as a Patient with Vasculitis", 2022 International Vasculitis Symposium, Chicago, IL, 07/16/2022 |
"Update in ANCA Vasculitis", Rheumatology Alliance of Louisiana - Annual Meeting, New Orleans, 08/13/2022 |
"Rheumatology Online: Disseminating the State of the Art on Social Media", ACR Convergence, Philadelphia, PA, 11/11/2022 |
"Polymyalgia Rheumatica - New Tricks for an Old Disease", ACR Convergence, Philadelphia, PA, 11/13/2022 |
“Myths & Mistakes from the Medical Literature”, Rheum Now Live, Dallas, Texas, 01/28/2023 |
"Neither Hard Nor Cookbook Nor Healthy: The State of Evidence Based Medicine", Rheumatology Grand Rounds, Einstein College of Medicine, New York, New York, 03/24/2023 |
"Keeping Up with the Medical Literature", ACR Convergence, San Diego, 11/10/2023 |
"Moderator - ACR Knowledge Bowl", ACR Convergence Annual Meeting, San Diego, 11/12/2023 - 11/13/2023 |
"Going Viral: How to Achieve Podcast Success", ACR Convergence, San Diego, 11/12/2023 |
"Myths and Misconceptions: ANCA Associted Vasculitis", RheumNow Live, Dallas, TX, 01/27/2024 - 01/28/2024 |
"Common Problems in Common Projects: Reading Better in Rheumatology", Rutgers Rheumatology Grand Rounds, Newark, New Jersey, 02/07/2024 |
"Dignosis of EGPA", Vindico Vasculitis Series, Cleveland, OH, 05/06/2024 |
"Knowledge Bowl Host", ACR Convergence 2024, Washington, DC, 11/10/2024 - 11/14/2024 |
"Stirring the POTS: Long COVID and Beyond", ACR Convergence 2024, Washington, DC, 11/16/2024 |
"Envisioning Steroid-Free Future", ACR Convergence 2024, Washington DC, 11/17/2024 |
"Pneumocystis Jerovecii Pneumonia among Patents with Rheumatic Diseases: Analaysis of the Veterans Affairs Database", ACR Convergence 2024, Washington DC, 11/17/2024 |
Regional |
"A Critical Appraisal of Critical Appraisal", Wisconsin Rheumatism Association, Kohler, Wisconsin, 03/07/2024 |
"The State of Rheumatology in 2024", Cal Brown Day Memorial Meeting, Chicago, IL, 05/24/2024 |
"State of the Art in PMR", ARTS Rheumatology Symposium, Chicago, IL, 09/07/2024 |
"CAR-T: Defining the Next Steps in Rheumatoloyg", ARTS Rheumatology Symposium, Chicago, IL, 09/08/2024 |
Local |
"From Chewing Gum to Functional Genomics: Improving Diagnosis in Giant Cell Arteritis", Rheumatology presentation, Medical College of Wisconsin - HUB 8th floor, 06/05/2019 |
"Eye on the Prize: Early Diagnosis in GCA", Ophthalmology Grand Rounds, Medical College of Wisconsin, 02/03/2020 |
"A Bayesian Approach to Early Diagnosis in GCA", Vascular Surgery Grand Rounds, Medical College of Wisconsin, 05/25/2021 |
"The Modern Approach to GCA", Grand Rounds, Watertown, WI, 05/20/2022 |
“Pneumocystis Jerovecii Pneumonia Prophylaxis: A Reassessment”, Department of Medicine Quality Committee Meeting, Medical College of Wisconsin, 08/04/2022 |
“Fast Flexible Epidemiology: TriNetX at MCW”, Hematology Oncology Faculty Meeting, Milwaukee, WI, 10/18/2022 |
"Writing Editorials: 'Hospital Problems'", KICS Journal Club, Medical College of Wisconsin, 02/14/2023 |
"Not-Small Vessel Vasculitis", Vascular Surgery Grand Rounds, Medical College of Wisconsin, 02/13/2024 |
"Accelerating Research with the TriNetX Database", Research Committee Meeting, Medical College of Wisconsin, 02/14/2024 |
"Pathologies of Common Study Designs", Medical College of Wisconsin Pathology Grand Rounds, Milwaukee, WI, 05/10/2024 |
COMMITTEE SERVICE: |
Medical College of Wisconsin |
09/01/2020 - Present Member, Innovative Therapies P&T Committee |
09/2020 - 12/2020 Rheumatology Candidate Selection Committee, Rheumatology, Medicine, Medical College of Wisconsin |
03/01/2021 - 06/01/2023 Member, MCW Curriculum Development - Cross Thread Committee, The Medical College of Wisconsin |
09/2021 - 12/2021 Rheumatology Candidate Selection Committee, Rheumatology, Medicine, Medical College of Wisconsin |
08/01/2022 - Present Research Retreat Committee, Medicine, Medical College of Wisconsin |
08/01/2022 - 06/01/2023 Member, MCWFusion - Spiral Week Content Committee, Medical College of Wisconsin |
09/2022 - 03/2023 Internal Medicine Candidate Selection Committee, Medicine, Medical College of Wisconsin |
09/2022 - 12/2022 Rheumatology Candidate Selection Committee, Rheumatology, Medicine, Medical College of Wisconsin |
09/20/2023 - Present Member, Faculty Development Committee, Medicine, Medical College of Wisconsin |
09/2023 - 03/2024 Internal Medicine Candidate Selection Committee, Medicine, Medical College of Wisconsin |
09/2023 - 12/2023 Rheumatology Candidate Selection Committee, Rheumatology, Medicine, Medical College of Wisconsin |
06/18/2024 - Present Department of Medicine - Data Science Council, Medicine, Medical College of Wisconsin |
09/2024 - 12/2024 Rheumatology Candidate Selection Committee, Rheumatology, Medicine, Medical College of Wisconsin |
MCW TEACHING ACTIVITIES: |
Medical Student Education |
09/09/2020 Bench to Bedside Preceptor |
10/2020 - Present M4 Clinical Preceptor - 1 Month Rotation, 4 Students to Date |
01/01/2021 - Present M1 Clinical Apprenticeship Preceptor - Three Students to Date (Meghan Schlithius, Eddie Linn, Sagar Matharu) and 23 teaching sessions |
01/10/2022 4th Annual MCW SHS Conference: Open House (IM & IM Subspecialties) Provide students opportunity to learn more about the specialty of rheumatology and preparation to pursue. |
01/19/2022 Diagnostic Reasoning to Medical Students Talk |
01/11/2023 Enchancing DIagnostic Reasoning - M1 Lecture |
Resident and Fellow Education |
09/2020 - Present Rheumatology Fellowship Journal Club (2 Presentations per Year, 7 Total to Date) |
10/01/2020 - 10/01/2021 RheumChalk Lecture Series - weekly lecture for trainees |
10/2020 - Present Teach in outpatient Rheumatology clinic and inpatient consult service |
01/01/2021 - 09/01/2022 Medical School Diagnostic Reasoning Faculty Preceptor |
07/14/2021 Internal Medicine Residency Academic Half Day - The Systemic Vasculitidies |
07/21/2021 Internal Medicine Residency Academic Half Day Day - Update in Myositis |
10/31/2022 Internal Medicine Residency LOCAS Program - Program Overview and Objectives |
11/02/2022 - Present Faculty Preceptor, Internal Medicine Residency PGY2/3 Journal Club - Precept 10 Journal Clubs per Year (22 to date) |
11/17/2022 Internal Medicine Residency LOCAS Program - Study Designs for Resident Research |
12/07/2022 - Present Faculty Preceptor, Internal Medicine Residency PGY1 Journal Club - Precept 7Journal Clubs per Year (11 to date) |
12/07/2022 Internal Medicine Residency Academic Half Day: Vasculitis Controversies |
EXTRAMURAL TEACHING: |
Medical Student Education |
09/01/2017 - 03/01/2020 Northwestern Feinberg School of Medicine, Medical Decision Making Faculty Preceptor |
09/09/2021 Bench to Bedside Preceptor |
PROGRAMMATIC DEVELOPMENTS: |
Educational Programs |
Student |
01/01/2022 - 07/01/2023 MCWFusion - Curriculum Reform Participation - Attended retreats, created Critical Thinking Thread, (with Jay Patel) and built Hematology / Immunology Block (Role: Co-Director with Neil Hogg) |
Resident |
08/01/2022 - Present Longitudinal Curriculum for Advanced Scholarship - Mentored Resident Research Elective |
08/01/2022 - Present Internal Medicine Resident Journal Club - Structural Intervention |
COMMUNITY SERVICE ACTIVITIES: |
05/22/2021 Program Chair and Expert Panelist for WISN radio's "The Word on Medicine - Rheumatology," Milwaukee Wisconsin |
EVIDENCE BASED RHEUMATOLOGY PODCAST: |
01/01/2018 - Present Twice monthly podcast about evidence-based medicine and rheumatology
Over 100 episodes and over 250,000 unique downloads from over 80 different countries |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Charles PD, Gill CE, Taylor HM, Putman MS, Blair CR, Roberts AG, Ayers GD, Konrad PE. Spasticity treatment facilitates direct care delivery for adults with profound intellectual disability. Mov Disord. 2010 Mar 15;25(4):466-73. |
2. Putman MS, Yoon JD, Rasinski KA, Curlin FA. Intentional sedation to unconsciousness at the end of life: findings from a national physician survey. J Pain Symptom Manage. 2013 Sep;46(3):326-34. |
3. Putman MS, Yoon JD, Rasinski KA, Curlin FA. Directive counsel and morally controversial medical decision-making: findings from two national surveys of primary care physicians. J Gen Intern Med. 2014 Feb;29(2):335-40. PMCID: PMC3912309 |
4. Putman M, Reddy S, Siebert D, Espinoza J, Jones K. Student-run free clinics and complementary curricula. Med Teach. 2014 Dec;36(12):1087-8. |
5. Siddiqui M, Putman MS, Dua AB. Adult-onset Still's disease: current challenges and future prospects. Open Access Rheumatol. 2016;8:17-22. PMCID: PMC5098765 |
6. Putman MS, Tak HJ, Curlin FA, Yoon JD. Quality of Life and Recommendations for Further Care. Crit Care Med. 2016 Nov;44(11):1996-2002. |
7. Putman MS, D'Alessandro A, Curlin FA, Yoon JD. Unilateral Do Not Resuscitate Orders: Physician Attitudes and Practices. Chest. 2017 Jul;152(1):224-225. |
8. Prochaska MT, Putman MS, Tak HJ, Yoon JD, Curlin FA. US Physicians Overwhelmingly Endorse Hospice as the Better Option for Most Patients at the End of Life. Am J Hosp Palliat Care. 2017 Jul;34(6):556-558. |
9. Sharma N, Putman MS, Vij R, Strek ME, Dua A. Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. J Rheumatol. 2017 Nov;44(11):1612-1618. |
10. Sattui SE, Liew JW, Graef ER, Coler-Reilly A, Berenbaum F, Duarte-García A, Harrison C, Konig MF, Korsten P, Putman MS, Robinson PC, Sirotich E, Ugarte-Gil MF, Webb K, Young KJ, Kim AHJ, Sparks JA. Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19. Expert Rev Clin Immunol. 2020 Jul;16(7):659-666. PMCID: PMC7594186 |
11. Putman MS, Harrison Ragle A, Ruderman EM. The Quality of Randomized Controlled Trials in High-impact Rheumatology Journals, 1998-2018. J Rheumatol. 2020 Sep 01;47(9):1446-1449. PMCID: PMC7483963 |
12. Duron G, Gelman L, Dua A, Putman M. Tracking clinical resources for coronavirus disease 2019. Curr Opin Rheumatol. 2020 Sep;32(5):441-448. |
13. Kilian A, Chock YP, Huang IJ, Graef ER, Upton LA, Khilnani A, Krupnikova SDS, Almaghlouth I, Cappelli LC, Fernandez-Ruiz R, Frankel BA, Frankovich J, Harrison C, Kumar B, Monga K, Vega JAR, Singh N, Sparks JA, Sullo E, Young KJ, Duarte-Garcia A, Putman M, Johnson S, Grainger R, Wallace ZS, Liew JW, Jayatilleke A. Acute respiratory viral adverse events during use of antirheumatic disease therapies: A scoping review. Semin Arthritis Rheum. 2020 Oct;50(5):1191-1201. PMCID: PMC7832282 |
14. Putman MS, Ruderman EM, Niforatos JD. Publication Rate and Journal Review Time of COVID-19-Related Research. Mayo Clin Proc. 2020 Oct;95(10):2290-2291. PMCID: PMC7458065 |
15. Putman M, Chock YPE, Tam H, Kim AHJ, Sattui SE, Berenbaum F, Danila MI, Korsten P, Sanchez-Alvarez C, Sparks JA, Coates LC, Palmerlee C, Peirce A, Jayatilleke A, Johnson SR, Kilian A, Liew J, Prokop LJ, Murad MH, Grainger R, Wallace ZS, Duarte-García A, COVID-19 Global Rheumatology Alliance. Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis. Arthritis Rheumatol. 2021 Jan;73(1):36-47. PMCID: PMC7435536 |
16. Mackie SL, Brouwer E, Conway R, van der Geest KSM, Mehta P, Mollan SP, Neill L, Putman M, Robinson PC, Sattui SE. Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective. Lancet Rheumatol. 2021 Jan;3(1):e71-e82. PMCID: PMC7834492 |
17. Putman MS, Chaitoff A, Niforatos JD. Publication Trends in Rheumatology Systematic Reviews and Randomized Clinical Trials, 1995-2017. J Rheumatol. 2021 Feb;48(2):305-306. |
18. Valenzuela-Almada MO, Putman MS, Duarte-García A. The protective effect of rheumatic disease agents in COVID-19. Best Pract Res Clin Rheumatol. 2021 Mar;35(1):101659. PMCID: PMC7833968 |
19. Hacker ML, Putman MS, Gill CE, Turchan M, Hudson TS, Currie AD, Phibbs FT, Charles D. Long-Term Care Resident Awareness and Interest in Spasticity Treatments. Geriatrics (Basel). 2021 Mar 03;6(1). PMCID: PMC7930982 |
20. Niforatos JD, Zheutlin AR, Putman MS, Weaver M, Chaitoff A. Trends in Published Clinical Trial Phases Among Surgical Specialties, 2007-2017. Ann Surg. 2021 May 01;273(5):e178-e179. |
21. Mehta P, Sattui SE, van der Geest KSM, Brouwer E, Conway R, Putman MS, Robinson PC, Mackie SL. Giant Cell Arteritis and COVID-19: Similarities and Discriminators. A Systematic Literature Review. J Rheumatol. 2021 Jul;48(7):1053-1059. |
22. Mbonu IV, Nemesh I, Suelzer E, Thorgerson A, Putman M. Authorship Trends in the Rheumatology Literature, 1990-2020. J Rheumatol. 2021 Sep;48(9):1493-1494. |
23. Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpízar-Rodríguez D, Berenbaum F, Bulina I, Conway R, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard RA, Hoyer BF, Hsieh E, El Kibbi L, Kilian A, Kim AH, Liew DFL, Lo C, Miller B, Mingolla S, Nudel M, Palmerlee CA, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché M, Levine M, Foster G, Thabane L, Rider LG, Hausmann JS, Simard JF, Sparks JA. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. 2021 Sep;7(3). PMCID: PMC8424419 |
24. Putman M, Kong N, Lomasney J, Stone NJ, Varga J. Extensive soft tissue xanthomatosis masquerading as tophaceous gout in a normolipidemic man. Rheumatology (Oxford). 2021 Nov 03;60(11):e381-e383. |
25. Putman MS, Goldsher JE, Crowson CS, Duarte-García A. Industry Payments to Practicing US Rheumatologists, 2014-2019. Arthritis Rheumatol. 2021 Nov;73(11):2138-2144. |
26. Sattui SE, Conway R, Putman MS, Seet AM, Gianfrancesco MA, Beins K, Hill C, Liew D, Mackie SL, Mehta P, Neill L, Gomez G, Salinas MIH, Maldonado FN, Mariz HA, de Sousa Studart SA, Araujo NC, Knight A, Rozza D, Quartuccio L, Samson M, Bally S, Maria AT, Chazerain P, Hasseli R, Müller-Ladner U, Hoyer BF, Voll R, Torres RP, Luis M, Ribeirio SLE, Al-Emadi S, Sparks JA, Hsu TY, D'Silva KM, Patel NJ, Wise L, Gilbert E, Almada MV, Duarte-García A, Ugarte-Gil M, Jacobsohn L, Izadi Z, Strangfeld A, Mateus EF, Hyrich KL, Gossec L, Carmona L, Lawson-Tovey S, Kearsley-Fleet L, Schaefer M, Sirotich E, Hausmann JS, Sufka P, Bhana S, Liew JW, Grainger R, Machado PM, Wallace ZS, Yazdany J, Robinson PC, Global Rheumatology Alliance. Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study. Lancet Rheumatol. 2021 Dec;3(12):e855-e864. PMCID: PMC8570701 |
27. Feterman Jimenez D, Duron G, Hendin J, Mantovani Cardoso E, Valenzuela-Almada MO, Vallejo S, Duarte-Garcia A, Sufka P, Whittle SL, Robinson PC, Prokop LJ, Putman MS. Industry involvement in rheumatology consensus-based recommendations: a systematic review The Lancet Rheumatology. 2021 Dec. |
28. Conway R, Putman MS, Mackie SL. Benchmarking tocilizumab use for giant cell arteritis. Rheumatol Adv Pract. 2022;6(2):rkac037. PMCID: PMC9115674 |
29. Chock EY, Putman M, Conway R, Danila MI, Hoyer B, Hsieh E, Jayatilleke A, Kilian A, Leipe J, Liew JW, Machado PM, Robinson PC, Singh N, Ung N, Yeoh SA, Wallace ZS, Grainger R, Cappelli LC. Experience with telemedicine among rheumatology clinicians during the COVID-19 pandemic: an international survey. Rheumatol Adv Pract. 2022;6(2):rkac039. PMCID: PMC9154733 |
30. Yeoh SA, Young K, Putman M, Sattui S, Conway R, Graef E, Kilian A, Konig M, Sparks J, Ugarte-Gil M, Upton L, Berenbaum F, Bhana S, Costello W, Hausmann J, Machado P, Robinson P, Sirotich E, Sufka P, Yazdany J, Liew J, Grainger R, Wallace Z, Jayatilleke A, Global Rheumatology Alliance. Rapid Adoption of Telemedicine in Rheumatology Care During the COVID-19 Pandemic Highlights Training and Supervision Concerns Among Rheumatology Trainees. ACR Open Rheumatol. 2022 Feb;4(2):128-133. PMCID: PMC8652624 |
31. Duarte-García A, Crowson CS, McCoy RG, Herrin J, Lam V, Putman MS, Ross JS, Matteson EL, Shah ND. Association Between Payments by Pharmaceutical Manufacturers and Prescribing Behavior in Rheumatology. Mayo Clin Proc. 2022 Feb;97(2):250-260. PMCID: PMC9013005 |
32. Putman M, Kennedy K, Sirotich E, Liew JW, Sattui SE, Moni TT, Akpabio AA, Alpizar-Rodriguez D, Angevare S, Beesley RP, Berenbaum F, Bulina I, Chock YPE, Conway R, Duarte-García A, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard R, Hoyer BF, Hsieh E, El Kibbi L, Kilian A, Kim AHJ, Liew DFL, Lo C, Mateus EF, Miller B, Mingolla S, Nudel M, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Zamora-Tehozol EA, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché MJ, Levine M, Foster G, Thabane L, Hausmann JS, Sparks JA, Simard JF. COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. Lancet Rheumatol. 2022 Apr;4(4):e237-e240. PMCID: PMC8824526 |
33. Conway R, Grimshaw AA, Konig MF, Putman M, Duarte-García A, Tseng LY, Cabrera DM, Chock YPE, Degirmenci HB, Duff E, Egeli BH, Graef ER, Gupta A, Harkins P, Hoyer BF, Jayatilleke A, Jin S, Kasia C, Khilnani A, Kilian A, Kim AHJ, Lin CMA, Low C, Proulx L, Sattui SE, Singh N, Sparks JA, Tam H, Ugarte-Gil MF, Ung N, Wang K, Wise LM, Yang Z, Young KJ, Liew JW, Grainger R, Wallace ZS, Hsieh E, COVID-19 Global Rheumatology Alliance. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis. Arthritis Rheumatol. 2022 May;74(5):766-775. PMCID: PMC9011807 |
34. Putman MS, Gribbons KB, Ponte C, Robson J, Suppiah R, Craven A, Watts R, Luqmani R, Merkel PA, Archer AM, Grayson PC. Clinicopathologic Associations in a Large International Cohort of Patients With Giant Cell Arteritis. Arthritis Care Res (Hoboken). 2022 Jun;74(6):1013-1018. |
35. Putman M, Berquist JB, Ruderman EM, Sparks JA. Any Given Monday: Association Between Desk Rejections and Weekend Manuscript Submissions to Rheumatology Journals. J Rheumatol. 2022 Jun;49(6):652-653. |
36. Rider LG, Parks CG, Wilkerson J, Schiffenbauer AI, Kwok RK, Noroozi Farhadi P, Nazir S, Ritter R, Sirotich E, Kennedy K, Larche MJ, Levine M, Sattui SE, Liew JW, Harrison CO, Moni TT, Miller AK, Putman M, Hausmann J, Simard JF, Sparks JA, Miller FW, COVID-19 Global Rheumatology Alliance Vaccine Survey Group. Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID-19 global rheumatology alliance vaccine survey. Rheumatology (Oxford). 2022 Jun 28;61(SI2):SI143-SI150. PMCID: PMC9248066 |
37. DiIorio M, Kennedy K, Liew JW, Putman MS, Sirotich E, Sattui SE, Foster G, Harrison C, Larché MJ, Levine M, Moni TT, Thabane L, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Gore-Massy M, Howard RA, Kodhek MA, Lalonde N, Tomasella LA, Wallace J, Akpabio A, Alpízar-Rodríguez D, Beesley RP, Berenbaum F, Bulina I, Chock EY, Conway R, Duarte-García A, Duff E, Gheita TA, Graef ER, Hsieh E, El Kibbi L, Liew DF, Lo C, Nudel M, Singh AD, Singh JA, Singh N, Ugarte-Gil MF, Hausmann JS, Simard JF, Sparks JA. Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey. RMD Open. 2022 Sep;8(2). PMCID: PMC9475962 |
38. Henry K, Nepal D, Valley E, Pedersen C, Duarte-García A, Putman M. Comparative Efficacy Randomized Controlled Trials in Rheumatology Guidelines. ACR Open Rheumatol. 2022 Oct;4(10):897-902. PMCID: PMC9555191 |
39. Chevet B, Figueroa-Parra G, Yang JX, Hulshizer CA, Gunderson TM, Duong SQ, Putman MS, Barbour KE, Crowson CS, Duarte-García A. COVID-19 Vaccine Uptake Among Patients With Systemic Lupus Erythematosus in the American Midwest: The Lupus Midwest Network (LUMEN). J Rheumatol. 2022 Nov;49(11):1276-1282. PMCID: PMC9633343 |
40. Tai S, Anumolu N, Putman M. Challenging wisely: how to move beyond '1 mg/kg then taper'. Rheumatology (Oxford). 2022 Dec 23;62(1):3-6. |
41. Coler-Reilly A, Graef ER, Kim AHJ, Liew JW, Putman MS, Sattui SE, Young KJ, Sparks JA. Social Media for Research Discourse, Dissemination, and Collaboration in Rheumatology. Rheumatol Immunol Res. 2022 Dec;3(4):169-179. PMCID: PMC9984924 |
42. Mbonu I, Tai S, Bartels CM, Putman M. Association Between Neighborhood Deprivation and Number of Rheumatology Providers. Arthritis Care Res (Hoboken). 2023 Jan;75(1):9-13. |
43. Anumolu N, Henry K, Sattui SE, Putman M. Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica? Semin Arthritis Rheum. 2023 Feb;58:152154. |
44. Singla S, Putman M, Liew J, Gordon K. Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study. Lancet Rheumatol. 2023 Apr;5(4):e200-e207. |
45. Gill T, Putman M, Sattui SE, Hamdulay S, Conway R, Liew DFL, Sharma A, Stone JH, Mackie SL, Mehta P. Giant cell arteritis can occur in people of colour. Lancet Rheumatol. 2023 Apr;5(4):e175-e177. |
46. Singla S, Putman M, Liew J, Gordon K. Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis - Authors' reply. Lancet Rheumatol. 2023 Jun;5(6):e313. |
47. Coler-Reilly A, Graef ER, Kim AHJ, Liew JW, Putman MS, Sattui SE, Young KJ, Sparks JA. Erratum to "Social media for research discourse, dissemination, and collaboration in rheumatology". Rheumatol Immunol Res. 2023 Jun;4(2):107-108. PMCID: PMC10457546 |
48. Gill T, Putman M, Sattui SE, Hamdulay S, Conway R, Liew DFL, Sharma A, Stone JH, Mackie SL, Mehta P. Should race be considered in diagnosing giant cell arteritis? - Authors' reply. Lancet Rheumatol. 2023 Jul;5(7):e372-e373. |
49. Nepal D, Putman M, Unizony S. Giant Cell Arteritis and Polymyalgia Rheumatica: Treatment Approaches and New Targets. Rheum Dis Clin North Am. 2023 Aug;49(3):505-521. |
50. Bruggemeyer C, Nepal D, Putman M. Unintentional unblinding in rheumatic disease trials. Lancet Rheumatol. 2023 Oct;5(10):e633-e636. |
51. Pedersen C, Tai S, Valley E, Henry K, Duarte-García A, Singla S, Putman M. Unpublished clinical trials of common rheumatic diseases. Rheumatology (Oxford). 2023 Dec 01;62(12):3811-3818. |
52. Henry K, Anumolu N, Putman M. Twenty-five years of novel drug approvals in rheumatology. Rheumatology (Oxford). 2023 Dec 01;62(12):3801-3803. |
53. Figueroa-Parra G, Putman MS, Crowson CS, Duarte-García A. Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies. Lupus Sci Med. 2024 Jan 10;11(1). PMCID: PMC10806519 |
54. Nettleton E, Sattui SE, Wallace Z, Putman M. Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide. Arthritis Care Res (Hoboken). 2024 Feb;76(2):288-294. PMCID: PMC10841679 |
55. Casey M, Pannu S, Bajwa S, Duarte-García A, Putman M. Risk of Neuroinflammatory Diseases Among New Recipients of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs. Arthritis Care Res (Hoboken). 2024 Aug;76(8):1203-1209. |
56. Kelly A, Carlson K, Wallace Z, Putman M. Positive and negative controls in rheumatology research. Rheumatology (Oxford). 2024 Aug 02. |
57. Figueroa-Parra G, Cuéllar-Gutiérrez MC, González-Treviño M, Sanchez-Rodriguez A, Flores-Gouyonnet J, Meade-Aguilar JA, Prokop LJ, Murad MH, Dall'Era M, Rovin BH, Houssiau F, Tamirou F, Fervenza FC, Crowson CS, Putman MS, Duarte-García A. Impact of Glucocorticoid Dose on Complete Response, Serious Infections, and Mortality During the Initial Therapy of Lupus Nephritis: A Systematic Review and Meta-Analysis of the Control Arms of Randomized Controlled Trials. Arthritis Rheumatol. 2024 Sep;76(9):1408-1418. |
58. Manswell K, Le V, Henry K, Casey M, Anumolu N, Putman MS. The State of Patient-Reported Outcome Measures in Rheumatology. J Rheumatol. 2024 Sep 01;51(9):920-927. |
59. Nettleton E, Carlson K, Putman M. The emerging risk of overdiagnosis in rheumatoid arthritis and polymyalgia rheumatica. Lancet Rheumatol. 2024 Sep 25. |
60. Keller KK, Mukhtyar CB, Nielsen AW, Hemmig AK, Mackie SL, Sattui SE, Hauge EM, Dua A, Helliwell T, Neill L, Blockmans D, Devauchelle-Pensec V, Hayes E, Venneboer AJ, Monti S, Ponte C, De Miguel E, Matza M, Warrington KJ, Byram K, Yaseen K, Peoples C, Putman M, Lally L, Finikiotis M, Appenzeller S, Caramori U, Toro-Gutiérrez CE, Backhouse E, Oviedo MCG, Pimentel-Quiroz VR, Keen HI, Owen CE, Daikeler T, de Thurah A, Schmidt WA, Brouwer E, Dejaco C. Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group. Ann Rheum Dis. 2024 Oct 21;83(11):1436-1442. |
61. Lungova K, Putman M. Barriers to CAR T-cell therapy in rheumatology. Lancet Rheumatol. 2024 Nov 05. |
62. Jiang Y, Duarte-García AA, Putman MS, Gazeley DJ. Incidence of <i>Pneumocystis jirovecii</i> Pneumonia and Prophylaxis-Associated Adverse Events Among Patients With Systemic Lupus Erythematosus. J Rheumatol. 2024 Dec 01. |
Editorials, Letters To Editor, Other |
1. Putman MS, Curlin FA. Authors' reply to Dirksen et al. J Pain Symptom Manage. 2013 May;45(5):e2-3. |
2. Putman M. Anifrolumab in Systemic Lupus Erythematosus. N Engl J Med. 2020 Apr 23;382(17):1665-1666. |
3. Putman MS, Sufka P, Whittle S, Robinson PC. European consensus statements for interstitial lung disease in systemic sclerosis The Lancet Rheumatology. June 2020;2(6):e317-e318. |
4. Graef ER, Liew JW, Putman MS, Simard JF, Sirotich E, Berenbaum F, Duarte-García A, Grainger R, Harrison C, Konig MF, Korsten P, Proulx L, Richards DP, Robinson PC, Sattui SE, Ugarte-Gil MF, Young KJ, Kim AH, Sparks JA, COVID-19 Global Rheumatology Alliance. <i>Festina lente</i>: hydroxychloroquine, COVID-19 and the role of the rheumatologist. Ann Rheum Dis. 2020 Jun;79(6):734-736. PMCID: PMC7359879 |
5. Kim AHJ, Sparks JA, Liew JW, Putman MS, Berenbaum F, Duarte-García A, Graef ER, Korsten P, Sattui SE, Sirotich E, Ugarte-Gil MF, Webb K, Grainger R, COVID-19 Global Rheumatology Alliance. A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19. Ann Intern Med. 2020 Jun 16;172(12):819-821. PMCID: PMC7138335 |
6. Putman MS, Ruderman EM. Learning from Adversity: Lessons from the COVID-19 Crisis. J Rheumatol. 2020 Jun 01;47(6):791-792. |
7. Velasco J, Singla S, Putman M, Thorgerson AA, Suelzer E, Crayne CB. Further Investigation of Representation of Women as Authors of Rheumatology Articles From 2005 to 2020: Comment on the Article by Bagga et al. Arthritis Rheumatol. 2021 Mar;73(3):546-547. |
8. Putman M, Sattui SE, Sparks JA, Liew JW, Grainger R, Duarte-García A. Reply. Arthritis Rheumatol. 2021 Sep;73(9):1767-1768. PMCID: PMC8251029 |
9. Conway R, Brouwer E, van der Geest KSM, Mackie SL, Mehta P, Putman M, Robinson P, Sattui S. Dr. Conway et al reply. J Rheumatol. 2022 Jan;49(1):120-121. |
10. Putman M, Sattui S, Conway R. Where do we go after GiACTA? Rheumatology (Oxford). 2022 Jul 06;61(7):2720-2721. |
11. Putman M, Patel JJ, Dua A. There is no diagnosis of exclusion in rheumatology. Rheumatology (Oxford). 2022 Dec 23;62(1):1-2. |
12. Putman M, Berquist JB, Ruderman EM, Sparks JA. Dr. Putman et al reply. J Rheumatol. 2023 Jan;50(1):157-158. |
13. Singla S, Putman M, Liew J, Gordon K. Differentiating biologics to prevent psoriatic arthritis in patients with psoriasis – Authors' reply The Lancet Rheumatology. June 2023;5(6):e313. |
14. Nepal D, Putman M. Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis. N Engl J Med. 2023 Jul 27;389(4):378-379. |
15. Putman M. Hospital Problems. N Engl J Med. 2023 Jul 13;389(2):103-105. |
16. Wallace ZS, Putman M. Weighing the Risks and Benefits of Pneumocystis Jirovecii Pneumonia Prophylaxis in Rituximab Users. Arthritis Rheumatol. 2023 Nov;75(11):1904-1906. PMCID: PMC10954214 |
17. Kaushik S, Junek M, Putman M. Advocating for better trials in rheumatology. Rheumatology (Oxford). 2023 Dec 01;62(12):3776-3777. |
18. Gill T, Putman M, Sattui SE, Hamdulay S, Conway R, Liew DFL, Sharma A, Stone JH, Mackie SL, Mehta P. Should race be considered in diagnosing giant cell arteritis? – Authors' reply The Lancet Rheumatology. July 2023;5(7):e372-e373. |
19. Gill B, Putman M. Interleukin-5 inhibition in eosinophilic granulomatosis with polyangiitis: time for another approach? Lancet Rheumatol. 2023 Dec;5(12):e698-e699. |
Non-Refereed Journal Publications/Original Papers |
1. Williams, T; Putman, MS. "Fellows Forum: Keep Up with the Literature & Organize Your Learning." The Rheumatologist. March 19, 2019. https://www.the-rheumatologist.org/article/fellows-forum-keep-up-with-the-literature-organize-your-learning/ |
2. Putman, MS. "FDA Approves Nintedanib for SSc-ILD, But Temper Your Expectations." The Rheumatologist. Dec 18, 2019. https://www.the-rheumatologist.org/article/fda-approves-nintedanib-for-ssc-ild-but-temper-your-expectations/ |
3. Putman, MS. "Rheumatology in the Age of COVID-19: HCQ Shortages driven by Small, Nonrandomized Study." The Rheumatologist. March 28, 2020. https://www.the-rheumatologist.org/article/rheumatology-in-the-age-of-covid-19-hcq-shortages-driven-by-small-nonrandomized-study/ |
4. Putman, MS. "Vasculitis Guidelines in Focus, Part 1: The Guideline Project" The Rheumatologist. August 31, 2021. https://www.the-rheumatologist.org/article/vasculitis-guidelines-in-focus-part-1-the-guideline-project/ |
5. Putman, MS. "Vasculitis Guidelines in Focus, Part 2: ANCA-Associated Vasculitis" The Rheumatologist. Sept 9, 2021. https://www.the-rheumatologist.org/article/vasculitis-guidelines-in-focus-part-2-anca-associated-vasculitis/ |
6. Putman, MS. "Vasculitis Guidelines in Focus, Part 3: EGPA." The Rheumatologist. Sept 14, 2021. https://www.the-rheumatologist.org/article/vasculitis-guidelines-in-focus-part-3-egpa/ |
7. Putman, MS. "Vasculitis Guidelines in Focus, Part 4: Polyarteritis Nodosa." The Rheumatologist. Sept 22, 2021. https://www.the-rheumatologist.org/article/vasculitis-guidelines-in-focus-part-4-polyarteritis-nodosa/ |
8. Putman, MS. "Vasculitis Guidelines in Focus, Part 5: Takayasu Arteritis." The Rheumatologist. Oct 11, 2021. https://www.the-rheumatologist.org/article/vasculitis-guidelines-in-focus-part-5-takayasu-arteritis/ |
9. Putman, MS. "Exciting Data for SLE: Plenaries from #ACR22", RheumNow, 12 November 2022. |
10. Putman, MS. "Marginality: Non Rheumatic Studies for the Rheumatologist." November 21, 2022. |
11. Putman, MS. "Polymyalgia Rheumatica in the Spotlight", RheumNow, 4 December 2022. |
12. Putman, MS. "Tearing Down the Evidence Pyramid." Sensible Medicine. February 18 2023. |
Abstracts |
1. 2014 ACR/ARHP Annual Meeting
Risk Factors for Prevalent and Progressive Bone Deficits Among Adult Men and Women with Cystic Fibrosis
Joshua Baker1, Putman Melissa2, Karen Herlyn3, Angela S. Pizzo4, Allen Lapey5, Joel Finklestein2 and Peter A. Merkel6, 1Medicine/Rheumatology, Philadelphia VA Medical Center, Philadelphia, PA, 2Harvard University, Boston, MA, 3Department of Rheumatology, University Hospital Schleswig-Holstein, Lübeck, Germany, 4Mercy Hospital, Portland, ME, 5Cystic Fibrosis Center and Division of Pediatric Pulmonology, Massachusetts General Hospital, Boston, MA, 6University of Pennsylvania, Philadelphia, PA
|
2. 2015 ACR/ARHP Annual Meeting
Myositis Associated Interstitial Lung Disease: Clinical Predictors of Failure to Conventional Treatment and Their Response to Tacrolimus
Niharika Sharma1, Anisha Dua1, Michael Putman2, Rekha Vij3 and Mary Strek3, 1Rheumatology, The University of Chicago, Chicago, IL, 2Internal Medicine, The University of Chicago, Chicago, IL, 3Pulmonology, The University of Chicago, Chicago, IL
|
3. 2019 ACR/ARP Annual Meeting
Clinicopathologic Associations in a Large International Cohort of Patients with Giant Cell Arteritis
Michael Putman1, K Bates Gribbons 2, Anthea Craven 3, Cristina Ponte 4, Joanna Robson 5, Ravi Suppiah 6, Richard Watts 7, Raashid Luqmani 3, Peter Merkel 8, Amy Archer 9 and Peter C. Grayson 10, 1Northwestern University, Chicago, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 3University of Oxford, Oxford, United Kingdom, 4Department of Rheumatology, Hospital de Santa Maria, Lisbon, Portugal
|
4. ACR Convergence 2020
Acute Respiratory Viral Adverse Events During Use of Antirheumatic Disease Therapies: A Scoping Review
Adam Kilian1, Yu Pei Eugenia Chock2, Irvin Huang3, Elizabeth Graef4, Laura Upton5, Aneka Khilnani6, Sonia Silinsky Krupnikova7, Ibrahim Almaghlouth8, Laura Cappelli9, Ruth Fernandez-Ruiz10, Brittany Frankel3, Jourdan Frankovich11, Carly Harrison12, Bharat Kumar13, Kanika Monga14, Jorge Rosario Vega11, Namrata Singh15, Jeffrey Sparks16, Elaine Sullo6, Kristen Young17, Ali Duarte-Garcia18, Michael Putman19, Sindhu Johnson20, Jean Liew3 and Aruni Jayatilleke21, 1George Washington University, Washington, DC
|
5. ACR Convergence 2020
A Systematic Review to Quantify the Extent of Pharmaceutical Company Involvement in Rheumatology Consensus-Based Recommendations
Dominique Feterman Jimenez1, Garret Duron2, Ali Duarte-Garcia3, Paul Sufka4, Samuel Whittle5, Philip Robinson6, Larry Prokop3 and Michael Putman7, 1UConn Health Center, Farmington, CT, 2HCA Memorial Health University Medical Center, Savannah, GA, 3Mayo Clinic, Rochester, MN, 4Healthpartners, St Paul, 5Rheumatology Unit, The Queen Elizabeth Hospital, Springfield, South Australia, Australia, 6University of Queensland, Herston, Queensland, Australia, 7Northwestern University, Chicago, IL
|
6. ACR Convergence 2020
Antirheumatic Disease Therapies in Patients with COVID-19: A Systematic Review and Meta-analysis
Michael Putman1, Yu Pei Eugenia Chock2, Herman Tam3, Alfred Kim4, Sebastian Sattui5, Francis Berenbaum6, Maria (Maio) Danila7, Peter Korsten8, Catalina Sanchez Alvarez9, Jeffrey Sparks10, Laura Coates11, Candace Palmerlee12, Andrea Pierce13, Arundathi Jayatilleke14, Sindhu Johnson15, Adam Kilian16, Jean Liew17, Larry Prokop9, Hassan Murad9, Rebecca Grainger18, Zachary Wallace19 and Ali Duarte-Garcia9, 1Northwestern University, Chicago, IL, 2Yale School of Medicine, Greenwich, CT, 3The Hospital for Sick Children, Toronto, ON, Canada
|
7. ACR Convergence 2021
Outcomes of COVID-19 Infection in Patients with Primary Systemic Vasculitis and Polymyalgia Rheumatica: Results from the COVID-19 Global Rheumatology Alliance Physician Registry
Sebastian Sattui1, Richard Conway2, Michael Putman3, Andrea Seet4, Kaley Beins5, Catherine Hill6, David Liew7, Sarah Mackie8, Puja Mehta9, Lorna Neill10, Gimena Gomez11, Maria Salinas12, Federico Maldonado13, Henrique Moriz14, Samia Studart15, NAFICE ARAUJO16, Ann Knight17, Davide Rozza18, Luca Quartuccio19, Maxime Samson20, Stephane Bally21, Alexandre Maria22, Pascal Chazerain23, Rebecca Hasseli24, Ulf Müller-Ladner25
|
8. ACR Convergence 2021
Association of Area Deprivation Index and Practice Patterns of Medicare Part D Rheumatologists
Shannon Tai1, Ikechukwu Mbonu2 and Michael Putman3, 1Medical College of Wisconsin, Milwaukee, WI, 2Medical College of Wisconsin, West Allis, WI, 3Medical College of Wisconsin, Brookfield, WI
|
9. ACR Convergence 2021
The Impact of COVID-19 on Rheumatology Trainee Health and Wellbeing: Results from the COVID-19 Global Rheumatology Alliance Trainee Survey
Kristen Young1, Su-Ann Yeoh2, Michael Putman3, Sebastian Sattui4, Richard Conway5, Elizabeth Graef6, Adam Killian7, Maximilian Konig8, Jeffrey Sparks9, Manuel Ugarte-Gil10, Laura Upton11, Francis Berenbaum12, Suleman Bhana13, Jonathan Hausmann14, Pedro Machado15, Philip Robinson16, Emily Sirotich17, Paul Sufka18, Jinoos Yazdany19, Jean Liew20, Rebecca Grainger21, Zachary Wallace22 and Aruni Jayatilleke23
|
10. ACR Convergence 2021
SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Disease: A Systematic Literature Review
Richard Conway1, Alyssa Grimshaw2, Maximilian Konig3, Michael Putman4, Ali Duarte-Garcia5, Candice Low6, Shangyi Jin7, Diego Cabrera8, Yu Pei Eugenia Chock9, Berk Degirmenci10, Eimear Duff11, Bugra Egeli12, Elizabeth Graef13, Akash Gupta14, Patricia Harkins15, Bimba Franziska Hoyer16, Aruni Jayatilleke17, Christopher Kasia18, Aneka Khilnani19, Adam Kilian20, Alfred Kim21, Chung Mun Alice Lin22, Laurie Proulx23, Sebastian Sattui24, Namrata Singh25, Jeffrey Sparks26, Herman Tam27, Leslie Yingzhijie Tseng2
|
11. ACR Convergence 2022
Incidence of Pneumocystis Jirovecii Pneumonia and Prophylaxis-Associated Adverse Events Among Patients with Systemic Lupus Erythematosus
Yiran Jiang1, Ali Duarte-Garcia2, Mike Putman3 and David Gazeley4, 1Medical College of Wisconsin, Milwaukee, WI, 2Mayo Clinic, Rochester, MN, 3The Medical College of Wisconsin, Milwaukee, WI, 4Medical College of Wisconsin, Wauwatosa, WI
|
12. ACR Convergence 2022
Apathy Measurement in a Cohort of Systemic Lupus Erythematosus
Mike Putman1, David Gazeley2 and Ikechukwu Mbonu3, 1The Medical College of Wisconsin, Milwaukee, WI, 2Medical College of Wisconsin, Wauwatosa, WI, 3Medical College of Wisconsin, Milwaukee, WI
|
13. ACR Convergence 2022
Comparative Effectiveness Randomized Controlled Trials in Rheumatology Guidelines
Kathryn Henry1, Desh Nepal2, Erin Valley2, Connor Pedersen2, Ali Duarte-Garcia3 and Mike Putman4, 1Medical College of Wisconsin, Manitowoc, WI, 2Medical College of Wisconsin, Milwaukee, WI, 3Mayo Clinic, Rochester, MN, 4The Medical College of Wisconsin, Milwaukee, WI
|
14. ACR Convergence 2022
Incidence of Pneumocystis Jiroveci Pneumonia in Patients with ANCA Vasculitis Initiating Therapy with Rituximab or Cyclophosphamide
Elizabeth Nettleton1, Sebastian Sattui2, Zachary Wallace3 and Mike Putman1, 1The Medical College of Wisconsin, Milwaukee, WI, 2University of Pittsburgh, Pittsburgh, PA, 3Massachusetts General Hospital, Boston, MA
|
15. ACR Convergence 2022
Unpublished Clinical Trials of Major Rheumatic Diseases
Connor Pedersen1, Mike Putman2, Erin Valley1, Kathryn Henry3, Ali Duarte-Garcia4, Shikha Singla5 and Shannon Tai1, 1Medical College of Wisconsin, Milwaukee, WI, 2The Medical College of Wisconsin, Milwaukee, WI, 3Medical College of Wisconsin, Manitowoc, WI, 4Mayo Clinic, Rochester, MN, 5MCW, Fox Point, WI
|
16. ACR Convergence 2022
Prevalence and Mortality of Interstitial Lung Abnormalities in Rheumatoid Arthritis and non-RA Comparators in a Multicenter Prospective Cohort
Gregory McDermott1, Keigo Hayashi2, Kazuki Yoshida1, Matthew Moll1, Michael Cho1, Tracy Doyle1, Paul Dellaripa1, Rachel Putman1, Raul San Jose Estepar1, George Washko1, Elizabeth Regan3, Hiroto Hatabu1, Gary M Hunninghake1, Edwin Silverman1 and Jeffrey Sparks4, 1Brigham and Women's Hospital, Boston, MA, 2Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
|
17. ACR Convergence 2022
Opioid and Pain Medication Prescribing by Rheumatologists for Medicare Part D Beneficiaries from 2013 to 2019
Erin Valley1, Connor Pedersen1, Kathryn Henry2, Ali Duarte-Garcia3, Viktoriya Sabchyshyn1 and Mike Putman4, 1Medical College of Wisconsin, Milwaukee, WI, 2Medical College of Wisconsin, Manitowoc, WI, 3Mayo Clinic, Rochester, MN, 4The Medical College of Wisconsin, Milwaukee, WI
|
18. ACR Convergence November 2023 - San Diego, CA - Pneumocystis Jirovecii Pneumonia in Patients with Inflammatory Myopathies
Cody Bruggemeyer1, Sanket Shah2, Didem Saygin3 and Mike Putman4, 1Medical College of Wisconsin, Wauwatosa, WI, 2Medical College of Wisconsin, Milwaukee, WI, 3University of Pittsburgh, Pittsburgh, PA, 4Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI
|
19. ACR Convergence November 2023 – San Diego, CA Non-random Sampling in Rheumatology Randomized Controlled Trials: Evidence of Concerning Trial Conduct? Victoria Le1, Mats Junek2, Mike Putman3, Maximilian Casey1, Kenrick Manswell1, Jay Goldsher1, Elizabeth Nettleton1, Desh Nepal1 and Sanket Shah1, 1Medical College of Wisconsin, Milwaukee, WI, 2McMaster University, Hamilton, ON, Canada, 3Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI
|
20. ACR Convergence November 2023 – San Diego, CA - Risk of Inflammatory Central Nervous System Diseases Among New Users of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Maximilian Casey1, Sonia Pannu2, Saffia Bajwa3, Ali Duarte-Garcia4 and Mike Putman5, 1Medical College of Wisconsin, Milwaukee, WI, 2University School of Milwaukee, River Hills, WI, 3Medical College of Wisconsin, Wauwatosa, WI, 4Mayo Clinic, Rochester, MN, 5Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI
|
21. ACR Convergence November 2023 – San Diego, CA - Thromboembolic Risk Associated with Intravenous Immune Globulin Use in Patients with Idiopathic Inflammatory Myopathy: A Large Database Study Rohan Mehta1, Mike Putman2 and Didem Saygin3, 1Medical College of Wisconsin, Milwaukee, WI, 2Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI, 3University of Pittsburgh, Pittsburgh, PA
|
22. ACR Convergence November 2023 – San Diego, CA - Fragility of Randomized Clinical Trials of Systemic Lupus Erythematosus and Lupus Nephritis Therapies Gabriel Figueroa-Parra1, Mike Putman2 and Ali Duarte-Garcia3, 1Division of Rheumatology, Mayo Clinic, Rochester, MN, 2Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI, 3Mayo Clinic, Rochester, MN
|
23. ACR Convergence November 2023 – San Diego, CA - Recommendations for Early Referral of Patients with Suspected Polymyalgia Rheumatica: An Initiative from the International Giant Cell Arteritis and Polymyalgia Rheumatica Study Group Kresten Keller1, Chetan Mukhtyar2, Andreas Wiggers Nielsen3, Andrea Hemmig4, Sarah Mackie5, Sebastian Sattui6, Ellen Margrethe Hauge3, Anisha Dua7, Toby Helliwell8, Lorna Neil9, Daniel Blockmans10, Valerie Devauchelle11, eric Hayes3, Annett Jansen Venneboer12, Sara Monti13, Cristina Ponte14, Eugenio De Miguel15, Mark Matza16, Kenneth Warrington17, Kevin Byram18, Kinanah Yaseen19, Christine Peoples20, Mike Putman21, Lindsay Lally22, Michael Finikiotis20, Simone Appenzeller23, Ugo Carmori23, CARLOS ENRIQUE TORO GUTIERREZ24, Elisabeth Backhouse25, Maria Camila Guerrero26, Victor Pimentel-Quiroz27, Helen Keen25, Claire Owen28, |
24. ACR Convergence November 2023 – San Diego, CA - Risk of Gastrointestinal Perforation Among Patients with Giant Cell Arteritis Who Received Tocilizumab Desh Nepal1, Sebastian Sattui2, Zachary Wallace3 and Mike Putman4, 1Medical College of Wisconsin, Milwaukee, WI, 2University of Pittsburgh, Pittsburgh, PA, 3Massachusetts General Hospital, Newton, MA, 4Division of Rheumatology, Medical College of Wisconsin, Milwaukee, WI
|
25. Desh Nepal, Sebastian Sattui, Zach Wallace, Michael Putman. Risk of GI perforation among patients with GCA who received tocilizumab. 21st International Vasculitis Workshop April 7-10, 2024 Barcelona, Spain - Ref# 300 |
26. Kylie Carlson, April Jorge, Baijun Zhou, Zach Wallace, Michael Putman.
Association between major adverse cardiac events an exposure to sodium glucose contrasporter-2 (SGLT2) inhibitors among patients with ANCA associated vasculitis. 21st International Vasculitis Workshop April 7-10, 2024 Barcelona, Spain - Ref# 335 |
27. Desh Nepal, Himani Madnawat, Sebastian Sattui, Zach Wallace, Michael Putman. Risk of major adverse cardiac events among patients with giant cell arteritis who received tocilizumab. 21st International Vasculitis Workshop April 7-10, 2024 Barcelona, Spain - Ref# 336 |
28. Michael Putman, Nader Khalidi, Carol Langford, Curry Koening, Christian Pagnoux, David Cuthbertson, Carol McAlear, Peter Merkel. Clinicopathologic associations between macrophage phenotype and topography in giant cell arteritis. 21st International Vasculitis Workshop April 7-10, 2024 Barcelona, Spain - Ref# 339 |
Non-Peer Reviewed Educational Products |
1. Putman, MS. "The Differential: Re-Diagnosing Immune Mediated Inflammatory Disease." Figure 1. August 15, 2021. |
2. Putman, MS. "The Differential: FDA Approves Anifrolumab for SLE - Should You?" Figure 1. October 4th, 2021. |
3. Putman, MS. "The Differential: FDA Approves Avacopan - What Now?" Figure 1. December 1st, 2021. |
4. Putman, MS. "The Differential: When can your patient with RA taper off therapy?" Figure 1. December 16th, 2021. |
5. Putman MS. "The Differential: Negative trials in Sjögren's syndrome." Figure 1. January 27th, 2022. |
6. Putman, MS. "The Differential: ORAL Surveillance: A Non-Selective JAK Inhibitor Causes Cancer and CVD" Figure 1. February 14th, 2022. |
7. Putman MS. "The Differential: RheumMadness!" Figure 1. February 23rd, 2022. |
8. Putman MS. "The Differential: What's the role of TA Ultrasound?" Figure 1. March 17th, 2022. |
9. Putman MS. "The Differential: COVID-19 Updates." Figure 1. April 6th, 2022. |
10. Putman MS. "The Differential: Rheumatologists Role in Pericarditis." Figure 1. April 19th, 2022. |
11. Putman, MS. "Steroid Tapering in Rheumatoid Arthritis." Figure1. 8 May 2022. |
12. Putman, MS. "Time to Rethink Gabapentin Prescribing?" Figure1. May 16 2022. |
13. Putman, MS. "Food for Thought? Trials of Dietary Interventions in Rheumatology." Figure 1. June 24 2022. |
14. Putman, MS. "Patient Reported Outcome Measures: The Primary that Matters." Figure 1. July 18 2022. |
15. Putman, MS. "Placebo Effects in Osteoarthritis Research." Figure1. August 7 2022. |
16. Putman MS. "The Differential: Corticosteroid Tapering in Recent Trials." Figure 1. August 12th, 2022. |
17. Putman, MS. "Azathioprine is the Worst." Figure 1. August 18, 2022. |
18. Putman, MS. "High Cost of Good Intentions." Figure 1. 29 September 2022. |
19. Putman, MS. "ACR Convergence: A Preview." Figure 1. October 13, 2022. |
20. Putman, MS. "Is CAR-T the Future of Rheumatology?" Figure 1. November 11, 2022. |
21. Putman, MS. "Guidelines Update: TAK, GCA, RA." Figure 1. December 7 2022. |
22. Putman, MS. "Paradoxicality." Figure1. December 29 2022. |
23. Putman, MS. "Interventional Pharmacoeconomics." Figure1. January 12 2023. |
24. Putman, MS. "Rheumatology's Blind Spot." Figure1. January 27 2022. |
25. Putman, MS. "Potpourri 2: Target Trials." Figure 1. February 2, 2023. |
26. Putman, MS. "FDA Approves Sarilumab for PMR." Figure 1. March 26 2023. |
27. Putman, MS. ""Whas Up with PREOP Testing." Figure 1. April 13 2023. |
28. Putman, MS. "Long Awaited: Long COVID." Figure 1. May 10 2023. |
29. Putman, MS. "Peresolimab for Rheumatoid Arthritis." Figure 1. June 13 2023. |
30. Putman, MS. "TitAIN Study: Secukinumab in GCA." Figure 1. June 28 2023. |
31. Putman, MS. "Key Opinion Leaders and Pharmaceutical Influence." Figure 1. 07 July 2023. |
32. Putman, MS. "Keeping Up with the Medical Literature." Figure 1. 14 July 2023. |
33. Putman, MS. "Steroids and Rheumatoid Arthritis: More is Less?" Figure 1. August 25, 2023. |
34. Putman, MS. "Screening Studies: Promise and Pitfalls." Figure 1. September 7, 2023 |
35. Putman, MS. "Convergence Plenaries." Figure 1. September 29, 2023. |
36. Putman, MS. "Screening with Imaging for Polymyalgia Rheumatica." Figure 1. October 20, 2023. |
37. Putman, MS. "COVID-19 and Autoimmunity: Positive or Negative Controls?" Figure 1. November 5th, 2023. |
38. Putman, MS. "Stem Cell Transplantation for Systemic Sclerosis." Figure 1. Decmeber 18, 2023. |
39. Putman, M. "PEXIVAS Restrospective." Figure 1. January 10, 2024. |
40. Putman, M. "Low Dose Naltrexone Fails in Trial." Figure 1. January 20, 2024. |
41. Putman, M. "Can we prevent rheumatoid arthritis?" Figure 1. February 21, 2024. |
42. Putman, M. "RCT Potpourri #4." Figure 1. March 9, 2024. |
43. Putman, M. "Guidelines for Psoriatic Arthritis." Figure 1. March 21, 2024. |
44. Putman, M. "Perspective Potpourri." Figure 1. April 18, 2024. |
45. Putman, M. "What's an EGPA?" Figure 1. May 6, 2024. |
